Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Thrombectomy: Features

Interview
Simplifying Complex DVT Thrombectomy Cases With the New Protrieve Sheath
01/17/2023
VDM speaks with interventional radiologists Jeffrey Forris Beecham Chick, MD, MPH, and Abdullah Shaikh, MD, about their use of the Protrieve sheath from Inari Medical during complex DVT and IVC thrombectomy cases.
VDM speaks with interventional radiologists Jeffrey Forris Beecham Chick, MD, MPH, and Abdullah Shaikh, MD, about their use of the Protrieve sheath from Inari Medical during complex DVT and IVC thrombectomy cases.
VDM speaks with interventional...
01/17/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Global Trends in Thrombectomy Device and Systems Development: Retrospective Review Between 2000 and 2022
01/16/2023

J. T. Moon, H. Li, D. Iyer, Z. Bercu

J. T. Moon, H. Li, D. Iyer, Z. Bercu ...
Purpose: Novel technologies have shaped modern techniques in endovascular thrombectomy to ultimately improve outcomes for high-risk or critically ill patients. The purpose of our study was to examine global trends in thrombectomy device and...
Purpose: Novel technologies have shaped modern techniques in endovascular thrombectomy to ultimately improve outcomes for high-risk or critically ill patients. The purpose of our study was to examine global trends in thrombectomy device and...
Purpose: Novel technologies have...
01/16/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Time to Mechanical Thrombectomy Does Not Impact In-Hospital Outcomes for Acute Submassive Pulmonary Embolism
01/16/2023

Z. Khazi, A. Bhat

Z. Khazi, A. Bhat
Purpose: To determine if time to mechanical thrombectomy (MT) for submassive pulmonary embolism (PE) impacts length of hospital stay, 30-day readmission rate, and 30-day mortality rate. Materials and Methods: Retrospective review of all...
Purpose: To determine if time to mechanical thrombectomy (MT) for submassive pulmonary embolism (PE) impacts length of hospital stay, 30-day readmission rate, and 30-day mortality rate. Materials and Methods: Retrospective review of all...
Purpose: To determine if time to...
01/16/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Clot in Transit: Feasibility of Mechanical Thrombectomy
01/16/2023

M. A. Clifton, R. Quadri

M. A. Clifton, R. Quadri
Purpose: Clot in transit (CIT) is a high-risk mobile clot found in pericardiac or intracardiac locations. We examine a cohort of patients undergoing Inari device mechanical thrombectomy for known extensive thrombus as an alternative to...
Purpose: Clot in transit (CIT) is a high-risk mobile clot found in pericardiac or intracardiac locations. We examine a cohort of patients undergoing Inari device mechanical thrombectomy for known extensive thrombus as an alternative to...
Purpose: Clot in transit (CIT)...
01/16/2023
Vascular Disease Management
ISET 2023 ABSTRACT
The Use of AngioJet in Arterial, Venous, and Fistula Occlusion
01/16/2023
Purpose: AngioJet is a versatile mechanical thrombectomy device that has a role in acute vascular presentations. In our department, we use it for venous disease, fistula salvage, and acute arterial occlusions. We hypothesize that its utility...
Purpose: AngioJet is a versatile mechanical thrombectomy device that has a role in acute vascular presentations. In our department, we use it for venous disease, fistula salvage, and acute arterial occlusions. We hypothesize that its utility...
Purpose: AngioJet is a versatile...
01/16/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Percutaneous Mechanical Thrombectomy With the Inari ClotTriever Device in a Pediatric Population
01/16/2023

I. P. Rumball, K. Chen, N. Voutsinas, A. Noor

I. P. Rumball, K. Chen, N. Voutsinas,...
Purpose: Pediatric deep vein thrombosis (DVT) is rare, resulting in significant morbidity caused by postthrombotic syndrome (PTS). Catheter-directed therapy (CDT) and percutaneous mechanical thrombectomy (PMT) can decrease PTS severity in...
Purpose: Pediatric deep vein thrombosis (DVT) is rare, resulting in significant morbidity caused by postthrombotic syndrome (PTS). Catheter-directed therapy (CDT) and percutaneous mechanical thrombectomy (PMT) can decrease PTS severity in...
Purpose: Pediatric deep vein...
01/16/2023
Vascular Disease Management
News
CIS Is First in State to Use New Device System to Treat Vascular Disease
01/11/2023
OPELOUSAS, LA – Dr. Kalyan Veerina, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the state to use the Prodigy™ thrombectomy system at Opelousas General Health System (OGHS) to open blockages in...
OPELOUSAS, LA – Dr. Kalyan Veerina, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the state to use the Prodigy™ thrombectomy system at Opelousas General Health System (OGHS) to open blockages in...
OPELOUSAS, LA – Dr. Kalyan...
01/11/2023
Vascular Disease Management
Original Research
A Hybrid Approach to Acute Limb Ischemia Utilizing Indigo Aspiration Thrombectomy in Conjunction With Catheter-Directed Thrombolysis
02/16/2022
Improving limb salvage outcomes.
Improving limb salvage outcomes.
Improving limb salvage outcomes.
02/16/2022
Vascular Disease Management
Interview
Advanced Stroke Imaging in the Emergency Room: Saving Precious Time and Improving Patient Outcomes
06/29/2021
VDM speaks with neurointerventional surgeon Ryan A. McTaggart, MD, on the unique clinical pathway for stroke patients at Rhode Island Hospital, in Providence, Rhode Island.
VDM speaks with neurointerventional surgeon Ryan A. McTaggart, MD, on the unique clinical pathway for stroke patients at Rhode Island Hospital, in Providence, Rhode Island.
VDM speaks with...
06/29/2021
Vascular Disease Management
Case Report
A Patient With Spontaneous Pulmonary Embolism and Concomitant Deep Vein Thrombosis Treated With FlowTriever and ClotTriever Mechanical Thrombectomy
11/04/2019
Salimnia and colleagues describe the case of a 45-year-old man who presented with tachycardia, tachypnea, and hypoxemia.
Salimnia and colleagues describe the case of a 45-year-old man who presented with tachycardia, tachypnea, and hypoxemia.
Salimnia and colleagues describe...
11/04/2019
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement